Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
Authors
Keywords
-
Journal
Expert Opinion on Drug Delivery
Volume 14, Issue 7, Pages 851-864
Publisher
Informa UK Limited
Online
2016-10-12
DOI
10.1080/17425247.2016.1244187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Building the design, translation and development principles of polymeric nanomedicines using the case of clinically advanced poly(lactide(glycolide))–poly(ethylene glycol) nanotechnology as a model: An industrial viewpoint
- (2016) Harivardhan Reddy Lakkireddy et al. ADVANCED DRUG DELIVERY REVIEWS
- Key cost drivers of pharmaceutical clinical trials in the United States
- (2016) Aylin Sertkaya et al. Clinical Trials
- Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method
- (2016) Cyril Corbet et al. JOURNAL OF CONTROLLED RELEASE
- Emerging Frontiers in Drug Delivery
- (2016) Mark W. Tibbitt et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
- (2016) Daniel Bobo et al. PHARMACEUTICAL RESEARCH
- Regulatory aspects on nanomedicines
- (2015) Vanessa Sainz et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The similarity question for biologicals and non-biological complex drugs
- (2015) Daan J.A. Crommelin et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan–poly(ethylene imine) hybrid nanoparticles: A mechanistic insight
- (2015) Héloïse Ragelle et al. JOURNAL OF CONTROLLED RELEASE
- Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars
- (2015) Stefan Mühlebach et al. Nanomedicine
- Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown
- (2015) Anders Wittrup et al. NATURE BIOTECHNOLOGY
- Progress in material design for biomedical applications
- (2015) Mark W. Tibbitt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanomedicines: addressing the scientific and regulatory gap
- (2014) Sally Tinkle et al. Annals of the New York Academy of Sciences
- The use of theranostic gadolinium-based nanoprobes to improve radiotherapy efficacy
- (2014) L Sancey et al. BRITISH JOURNAL OF RADIOLOGY
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications
- (2014) Melissa A. Vetten et al. Nanomedicine-Nanotechnology Biology and Medicine
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Non-viral vectors for gene-based therapy
- (2014) Hao Yin et al. NATURE REVIEWS GENETICS
- How to Regulate Nonbiological Complex Drugs (NBCD) and Their Follow-on Versions: Points to Consider
- (2013) Huub Schellekens et al. AAPS Journal
- Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
- (2013) Nicolas Bertrand et al. ADVANCED DRUG DELIVERY REVIEWS
- Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
- (2013) Marina A. Dobrovolskaia et al. JOURNAL OF CONTROLLED RELEASE
- Next-generation nanomedicines and nanosimilars: EU regulators’ initiatives relating to the development and evaluation of nanomedicines
- (2013) Falk Ehmann et al. Nanomedicine
- Delivery materials for siRNA therapeutics
- (2013) Rosemary Kanasty et al. NATURE MATERIALS
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Challenges in Development of Nanoparticle-Based Therapeutics
- (2012) Neil Desai AAPS Journal
- αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
- (2012) Nora Graf et al. ACS Nano
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- Scientific considerations for complex drugs in light of established and emerging regulatory guidance
- (2012) Chris Holloway et al. Annals of the New York Academy of Sciences
- Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
- (2012) Nazila Kamaly et al. CHEMICAL SOCIETY REVIEWS
- Nanoscale radiotherapy with hafnium oxide nanoparticles
- (2012) Laurence Maggiorella et al. Future Oncology
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study
- (2012) Christoph Mamot et al. LANCET ONCOLOGY
- The big picture on nanomedicine: the state of investigational and approved nanomedicine products
- (2012) Michael L. Etheridge et al. Nanomedicine-Nanotechnology Biology and Medicine
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
- (2012) J. Hrkach et al. Science Translational Medicine
- Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention
- (2011) Janos Szebeni et al. ADVANCED DRUG DELIVERY REVIEWS
- Nanomedicine in cancer therapy: Innovative trends and prospects
- (2011) Elvin Blanco et al. CANCER SCIENCE
- Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy
- (2011) Daniel Zucker et al. JOURNAL OF CONTROLLED RELEASE
- In vitro and in vivo characterizations of PEGylated liposomal doxorubicin
- (2011) Wenlei Jiang et al. Bioanalysis
- The Design of Phase II Clinical Trials Testing Cancer Therapeutics: Consensus Recommendations from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee
- (2010) L. Seymour et al. CLINICAL CANCER RESEARCH
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Strategies in the design of nanoparticles for therapeutic applications
- (2010) Robby A. Petros et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of Nanotechnology on Drug Delivery
- (2009) Omid C. Farokhzad et al. ACS Nano
- Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel
- (2009) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Dose Escalation Methods in Phase I Cancer Clinical Trials
- (2009) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- Development of Lipidoid–siRNA Formulations for Systemic Delivery to the Liver
- (2009) Akin Akinc et al. MOLECULAR THERAPY
- Quality by design for biopharmaceuticals
- (2009) Anurag S Rathore et al. NATURE BIOTECHNOLOGY
- Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab-Paclitaxel
- (2008) E. R. Gardner et al. CLINICAL CANCER RESEARCH
- Methods for the Preparation and Manufacture of Polymeric Nanoparticles
- (2008) Christine Vauthier et al. PHARMACEUTICAL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search